Evidence map›Paper›PMID 8037693›Full record

ArticleThe Biochemical journal1994

Okadaic acid treatment leads to a fragmentation of the trans-Golgi network and an increase in expression of TGN38 at the cell surface.

M Horn, G Banting

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Rapsyn escorts the nicotinic acetylcholine receptor along the exocytic pathway via association with lipid rafts.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2002
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The organization of the Golgi complex and microtubules in skeletal muscle is fiber type-dependent.The Journal of neuroscience : the official journal of the Society for Neuroscience · 1999
    Article
  12. Article
  13. Evidence for the participation of the neuron-specific CDK5 activator P35 during laminin-enhanced axonal growth.The Journal of neuroscience : the official journal of the Society for Neuroscience · 1998
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

M HornDepartment of Biochemistry, School of Medical Sciences, University of Bristol, U.K.
G Banting
University of Bristol · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Okadaic acid (OA) is a protein phosphatase inhibitor which has, among other properties, previously been shown to induce a fragmentation of the cisternae of the Golgi stack [for review, see Lucocq (1992) J. Cell Sci. 103, 875-880]. The effects of OA an reversible and mimic intracellular events which occur during mitosis. To date, due to a lack of endogenous marker proteins, the effects of OA on the trans-Golgi network (TGN) has not been studied. Certain drugs, e.g. Brefeldin A (BFA), have different effects on the morphology of the Golgi stack and the TGN; it is therefore relevant to ask what effect(s) OA has on the TGN. We now present data from a study in which we have used antibodies to TGN38, an integral membrane protein predominantly localized to the TGN of rat NRK cells [Luzio, Brake, Banting, Howell, Braghetta and Stanley (1990) Biochem. J. 270, 97-102], to investigate the effects of OA on this organelle. OA induces a reversible fragmentation of the TGN. This fragmentation occurs with similar kinetics to that observed within the Golgi stack, and is independent of protein synthesis. The sensitivity of the TGN to OA is similar to that of the Golgi stack. The fragmentation of the TGN induced by OA also leads to a 10-fold increase in the level of TGN38 expressed at the plasma membrane.

Indexed as

GlycoproteinsMembrane ProteinsAmino Acid SequenceAnimalsCell LineCell MembraneCycloheximideEthers, CyclicFluorescent Antibody TechniqueGolgi ApparatusMembrane GlycoproteinsMolecular Sequence DataOkadaic AcidPeptide FragmentsRatsCycloheximideEthers, CyclicGlycoproteinsMembrane GlycoproteinsMembrane ProteinsOkadaic AcidPeptide FragmentsTgoln2 protein, rat

Identifiers

PMID8037693
PMCPMC1137144
OpenAlexW2267103400

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.